000			01968cam a22004934a 4500
005			20150712005536.0
008			070828s2008 ne af b 001 0 eng
010			_a 2007035586
016	7		_a101315286 _2DNLM
020			_a9780123695208 (alk. paper)
035			_a(OCoLC)ocn169452881
035			_a(OCoLC)169452881
040			_aDNLM/DLC _cDLC _dNLM _dBAKER _dBTCTA _dYDXCP _dC\P _dBWX _dDLC
042			_apcc
060	1	0	_aQV 744 _bK D
082	0	0	_a615.19 _222
084			_a615.19 _bK D
100	1		_aKerns, Edward Harvel.
245	1	0	_aDrug-like properties _h[[Book] :] _bconcepts, structure design and methods : from ADME to toxicity optimization / _cEdward H. Kerns and Li Di.
260			_aAmsterdam ; _aBoston : _bAcademic Press, _c2008.
300			_axix, 526 p., [2] p. of plates : _bill. (some col.) ; _c27 cm.
500			_aIncludes bibliographical references (p. 492) and index.
504			_aIncludes bibliographical references (p. 492) and index.
521			_aAll age.
650		0	_aPharmaceutical chemistry.
650		0	_aDrugs _xStructure-activity relationships.
650		0	_aDrug development.
650		0	_aDrugs _xDesign.
650	1	2	_aDrug Design.
650	2	2	_aDrug Evaluation, Preclinical.
650	2	2	_aDrug Toxicity.
650	2	2	_aPharmaceutical Preparations _xmetabolism.
650	2	2	_aPharmacokinetics.
650	2	2	_aStructure-Activity Relationship.
700	1		_aDi, Li.
856	4	1	_3Table of contents only _uhttp://www.loc.gov/catdir/toc/ecip0726/2007035586.html
856	4	2	_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0811/2007035586-d.html
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
925	1		_aacquire _b1 shelf copy _xpolicy default
955			_djc18 2007-09-04 _ejc18 2007-09-04 to Dewey _aaa27 2007-09-07 _aps10 2008-02-14 2 copies rec'd., to CIP ver. _fjx09 2008-02-27 Z-CipVer _gjx09 2008-02-27 c. 1-2 to BCCD
001			0000072786
003			0000
942			_cBK
999			_c55277 _d55277